Session » Clinical and Therapeutic Poster Breakout I
- 4:45PM-5:15PM
-
Abstract Number: 15
An Internet-based Self-management Program for Adolescents with Juvenile Idiopathic Arthritis – A Randomized Controlled Trial
- 4:45PM-5:15PM
-
Abstract Number: 14
Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial
- 4:45PM-5:15PM
-
Abstract Number: 13
Prevalence of Celiac Antibodies and IgA deficiency in Juvenile Idiopathic Arthritis
- 4:45PM-5:15PM
-
Abstract Number: 11
Safety of Adalimumab ± Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA): STRIVE Registry
- 4:45PM-5:15PM
-
Abstract Number: 12
Use of Ultrasound to Determine Remission Status in Children with Juvenile Idiopathic Arthritis